Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 667,951 | 657,568 | 604,569 | 601,530 | 585,295 |
| Cost of Goods | 421,835 | 419,464 | 392,792 | 375,113 | 369,095 |
| Gross Profit | 246,116 | 238,104 | 211,777 | 226,417 | 216,200 |
| Operating Expenses | 154,149 | 158,800 | 142,777 | 124,048 | 131,933 |
| Operating Income | 92,802 | 79,768 | 69,792 | 102,482 | 84,362 |
| Interest Expense | 5,698 | 20,835 | 9,987 | 16,741 | 17,197 |
| Other Income | -13,869 | 61 | 6,485 | -10,693 | 6,140 |
| Pre-tax Income | 73,235 | 58,994 | 66,290 | 75,048 | 73,305 |
| Income Tax | -317 | 14,685 | 10,602 | 14,850 | 12,403 |
| Net Income Continuous | 73,552 | 44,309 | 55,688 | 60,198 | 60,902 |
| Minority Interests | 742 | 581 | 555 | 533 | 534 |
| Net Income | $72,810 | $43,728 | $55,133 | $59,665 | $60,368 |
| EPS Basic Total Ops | 1.49 | 0.90 | 1.14 | 1.26 | 1.25 |
| EPS Basic Continuous Ops | 1.51 | 0.91 | 1.15 | 1.26 | 1.25 |
| EPS Diluted Total Ops | 1.46 | 0.88 | 1.11 | 1.22 | 1.22 |
| EPS Diluted Continuous Ops | 1.48 | 0.89 | 1.13 | 1.23 | 1.22 |
| EBITDA(a) | $144,560 | $128,914 | $115,150 | $144,063 | $127,954 |